EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The Efficacy of Volumetric Modulated Arc Therapy Combined With Chemotherapy, Brachytherapy, and Local Hyperthermia on Patients with Locally Advanced Cervical Cancer: A Retrospective Study

Ping Jiang, Shuhua Wei, Yan Bai, Ang Qu, Weijuan Jiang, Haitao Sun, Junjie Wang iD

Technology in Cancer Research & Treatment · 2023

DOI: 10.1177/15330338231185013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2023. Verfasst von Ping Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Peking University 3rd Hospital, Beijing, China. Hauptthemen laut MEDLINE: Radiotherapy, Intensity-Modulated, Uterine Cervical Neoplasms, Brachytherapy, Hyperthermia, Induced. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, the Key Specialty program of Natural Science Foundation of Beijing Municipality, the Special Fund of National Clinical Key Specialty Construction Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the clinical outcomes of volumetric modulated arc therapy (VMAT) followed by brachytherapy (BT), combined with chemotherapy, and local hyperthermia (HT) on locally advanced cervical cancer (LACC).

Methods

In total, 40 patients with FIGO stage IB1-IVB cervical cancer from January 2016 to December 2018 were selectively enrolled in this study. All patients were treated with VMAT (50.4 Gy/1.8 Gy/28 f) concurrent with cisplatin-based chemotherapy (40 mg/m 2 , q1w, 6 cycles) and local HT (40.5-41°C for 60 min, BIW). BT (30-36 y/5-6 f, 2 f/w) was conducted after VMAT. Objective response rate (ORR), local control (LC) time, LC rate, progression-free survival (PFS) rate, cancer-specific survival (CSS) rate, overall survival (OS), median time to tumor progression and treatment-related toxicity were evaluated.

Results

The median follow-up time was 31 months (8-48). The ORR was 100% at 3 months after treatment and 92.1% at 6 months, respectively. The 1-year, 2-year, and 3-year LC rates were 87.4%, 81.9%, and 70.9%, respectively. The average LC time was 31.50 ± 1.89 months (95% CI 27.79-35.21). The 1-year, 2-year, and 3-year PFS rates were 75.85%, 61.2%, and 51.3%, respectively, while the median PFS was 27.07 months. The 1-year, 2-year, and 3-year OS rates were 95%, 84%, and 79.6%, respectively. In total, 12(30%) patients had grade 3/4 bone marrow suppression. One patient had grade 4 leukopenia. In total, 17 patients had grade 1/2 bone marrow suppression. Two patients had grade 3 nausea and grade 3 vomiting reaction, respectively. No grade 3/4 proctitis and bladder reaction were observed. In the late period of treatment, 1 patient had a rectal hemorrhage. In total, 13 patients had vaginal stenosis.

Conclusion

VMAT concurrent with chemotherapy, BT, and local HT had a favorable short-term efficacy and acceptable toxicity on cervical cancer, which was an alternative option for LACC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiotherapy, Intensity-ModulatedUterine Cervical NeoplasmsBrachytherapyHyperthermia, InducedHumansFemaleRetrospective StudiesConstriction, PathologicChemoradiotherapyVaginaCisplatinTreatment Outcome

Stichwörter der Autor:innen

cervical cancerchemotherapyhyperthermiaradiotherapy

Substanzen

Cisplatin

Autor:innen und Institutionen

  • Department of Radiation Oncology, Peking University 3rd Hospital, Beijing, China.

ORCID-Profile: Junjie Wang

Förderung

  • National Natural Science Foundation of China
  • the Key Specialty program of Natural Science Foundation of Beijing Municipality
  • the Special Fund of National Clinical Key Specialty Construction Program of China

Zitieren

APA

Jiang, P., Wei, S., Bai, Y., Qu, A., Jiang, W., Sun, H., & Wang, J. (2023). The Efficacy of Volumetric Modulated Arc Therapy Combined With Chemotherapy, Brachytherapy, and Local Hyperthermia on Patients with Locally Advanced Cervical Cancer: A Retrospective Study. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338231185013

Vancouver

Jiang P, Wei S, Bai Y, Qu A, Jiang W, Sun H, et al. The Efficacy of Volumetric Modulated Arc Therapy Combined With Chemotherapy, Brachytherapy, and Local Hyperthermia on Patients with Locally Advanced Cervical Cancer: A Retrospective Study. Technology in Cancer Research & Treatment. 2023. doi:10.1177/15330338231185013

BibTeX
@article{Jiang2023,
  author = {Jiang, Ping and Wei, Shuhua and Bai, Yan and Qu, Ang and Jiang, Weijuan and Sun, Haitao and Wang, Junjie},
  title = {The Efficacy of Volumetric Modulated Arc Therapy Combined With Chemotherapy, Brachytherapy, and Local Hyperthermia on Patients with Locally Advanced Cervical Cancer: A Retrospective Study},
  journal = {Technology in Cancer Research & Treatment},
  year = {2023},
  doi = {10.1177/15330338231185013}
}
Kostenlos starten →